These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30692037)

  • 1. Low levels of vitamin D and the relationship between vitamin D and Th2 axis-related cytokines in neuromyelitis optica spectrum disorders.
    Gao M; Yao X; Ding J; Hong R; Wu Y; Huang H; Zhuang L; Li Z; Wang Y; Zhang Y; Guan Y
    J Clin Neurosci; 2019 Mar; 61():22-27. PubMed ID: 30692037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th2 axis-related cytokines in patients with neuromyelitis optica spectrum disorders.
    Zhang Y; Yao XY; Gao MC; Ding J; Hong RH; Huang H; Zhuang L; Wang YG; Hao Y; Guan YT
    CNS Neurosci Ther; 2018 Jan; 24(1):64-69. PubMed ID: 29110391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Vitamin D and Dexamethasone on Lymphocyte Proportions and Their Associations With Serum Concentrations of 25-Hydroxyvitamin D
    Cho EB; Shin JH; Kwon S; Kim J; Seok JM; Kim BJ; Min JH
    Front Immunol; 2021; 12():677041. PubMed ID: 34394078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low levels of vitamin D in neuromyelitis optica spectrum disorder: association with disease disability.
    Min JH; Waters P; Vincent A; Cho HJ; Joo BE; Woo SY; Lee SY; Shin HY; Lee KH; Kim BJ
    PLoS One; 2014; 9(9):e107274. PubMed ID: 25211011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum 25-hydroxyvitamin D
    Shan Y; Tan S; Zhang L; Huang J; Sun X; Wang Y; Cai W; Qiu W; Hu X; Lu Z
    J Neuroimmunol; 2016 Oct; 299():118-123. PubMed ID: 27725109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6.
    Wei Y; Chang H; Li X; Wang H; Du L; Zhou H; Xu W; Ma Y; Yin L; Zhang X
    Neuroimmunomodulation; 2018; 25(4):215-224. PubMed ID: 30544111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine and Chemokine Profiles in Patients with Neuromyelitis Optica Spectrum Disorder.
    Wang Y; Zhou Y; Sun X; Lu T; Wei L; Fang L; Chen C; Huang Q; Hu X; Lu Z; Peng L; Qiu W
    Neuroimmunomodulation; 2016; 23(5-6):352-358. PubMed ID: 28445879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum IL-36β and IL-36γ levels in patients with neuromyelitis optica spectrum disorders: association with disease activity.
    Yang CS; Zhang QX; Deng Y; Zhou BJ; Zhang LJ; Li LM; Qi Y; Wang J; Yang L; Shi FD
    BMC Neurol; 2019 Aug; 19(1):185. PubMed ID: 31382910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D status and the risk of neuromyelitis optica spectrum disorders: A systematic review and meta-analysis.
    Liu S; Tan B; Zhou J; Xiao L; Li M; Yin J
    J Clin Neurosci; 2024 Jan; 119():185-192. PubMed ID: 38113581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D Status in Children With Short Stature: Accurate Determination of Serum Vitamin D Components Using High-Performance Liquid Chromatography-Tandem Mass Spectrometry.
    Xu B; Feng Y; Gan L; Zhang Y; Jiang W; Feng J; Yu L
    Front Endocrinol (Lausanne); 2021; 12():707283. PubMed ID: 34721288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and application of a LC-MS/MS assay for simultaneous analysis of 25-hydroxyvitamin-D and 3-epi-25-hydroxyvitamin-D metabolites in canine serum.
    Hurst EA; Homer NZ; Denham SG; MacFarlane E; Campbell S; Boswinkel M; Mellanby RJ
    J Steroid Biochem Mol Biol; 2020 May; 199():105598. PubMed ID: 31958632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D level status in Thai neuromyelitis optica patients.
    Jitprapaikulsan J; Siritho S; Prayoonwiwat N
    J Neuroimmunol; 2016 Jun; 295-296():75-8. PubMed ID: 27235352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower serum interleukin-22 and interleukin-35 levels are associated with disease status in neuromyelitis optica spectrum disorders.
    Yang H; Han L; Zhou YJ; Ding J; Cai Y; Hong RH; Hao Y; Zhu DS; Shen XF; Guan YT
    CNS Neurosci Ther; 2020 Feb; 26(2):251-259. PubMed ID: 31342670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder: A multicenter cohort study.
    Kessler RA; Mealy MA; Jimenez-Arango JA; Quan C; Paul F; López R; Hopkins S; Levy M
    Mult Scler Relat Disord; 2017 Oct; 17():198-201. PubMed ID: 29055457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between serum levels of endothelin-1 and disease severity in patients with neuromyelitis optica spectrum disorders.
    Yi M; Liu MQ; Chou LS; Jiang SM; Zhang LJ; Huang CN; Wang N; Zhang QX; Yang L
    Immunobiology; 2020 May; 225(3):151959. PubMed ID: 32517881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance evaluation of four 25-hydroxyvitamin D assays to measure 25-hydroxyvitamin D2.
    Freeman J; Wilson K; Spears R; Shalhoub V; Sibley P
    Clin Biochem; 2015 Nov; 48(16-17):1097-104. PubMed ID: 26054580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low vitamin D-25(OH) level in Indonesian multiple sclerosis and neuromyelitis optic patients.
    Kusumadewi W; Imran D; Witjaksono F; Pakasi TA; Rusmana AI; Pangeran D; Marwadhani SS; Maharani K; Estiasari R
    Mult Scler Relat Disord; 2018 Oct; 25():329-333. PubMed ID: 30195201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased serum IL-27 and IL-35 levels are associated with disease severity in neuromyelitis optica spectrum disorders.
    Zhang DQ; Jia K; Wang R; Li T; Zhao N; Yang LN; Yang L
    J Neuroimmunol; 2016 Apr; 293():100-104. PubMed ID: 27049569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
    J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased frequency of IL-6-producing non-classical monocytes in neuromyelitis optica spectrum disorder.
    Kong BS; Kim Y; Kim GY; Hyun JW; Kim SH; Jeong A; Kim HJ
    J Neuroinflammation; 2017 Sep; 14(1):191. PubMed ID: 28946890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.